GeoVax Labs, Inc. (GOVX-OTC) Reports Vaccine Development Progress
GeoVax Labs announced today that its Chief Scientific Officer, Dr. Farshad Guirakhoo, will deliver a talk ...
August 2018 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)
Crystal Research Associates has issued a 13-page Quarterly Update on clinical-stage biotechnology company, ...
March 2018 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)
Crystal Research Associates has issued a 16-page Quarterly Update on clinical-stage biotechnology company, ...
October 2017 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)
Crystal Research Associates has issued a 15-page Quarterly Update on clinical-stage biotechnology company, ...
GeoVax Labs. (GOVX-OTC) Reports Promising Results for Lassa Fever Vaccine
Promising Results Reported for GeoVax's Lassa Fever Vaccine GeoVax announced today a significant step forward ...
New Research Released on GeoVax Labs, Inc. (GOVX-OTC)
An Executive Informational Overview (EIO) is now available on clinical-stage biotechnology company, GeoVax, ...
ASCO and IMS Health: Trends in the Cancer Care Market
Tomorrow kicks off one of the year’s largest oncology conferences: the American Society of Clinical Oncology ...
TapImmune's New State-of-the-Art Lab Facilities and Office Space
We recently received an update from TapImmune Inc. (TPIV-OTC.BB) regarding the Company's newly acquired ...